Ixchel Loses 9th Circ. Appeal In Antitrust Row With Biogen
The Ninth Circuit on Thursday held that a lower court did not err in dismissing claims from Ixchel Pharma LLC that Biogen Inc. illegally undermined its development of a neuromuscular disease...To view the full article, register now.
Already a subscriber? Click here to view full article